NCT05521035

Unknown

Risk and Incidence of Aortic Graft and Endograft Infection W...

Lund University Source

Other study identifiers

Sponsor study identifier

2022-5-BSI

Study Type

observational

Estimated enrollment

2,000

Locations

1 country

Sites

1

Timeline

Study Start

September 1, 2022

Actual (reported)

Primary Completion

September 1, 2024

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

September 1, 2024

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Brief Summary

What is the risk of aortic vascular graft and endograft infection in patients with aortic vascular graft/endograft and bloodstream infection?

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: unknown
Estimated enrollment: 2,000 participants
Study completion date: September 1, 2024
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

First Submitted
August 26, 2022
Actual (reported)
First Posted
August 30, 2022
Actual (reported)
Study Start
September 1, 2022
Actual (reported)
Primary Completion
September 1, 2024
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 1, 2024
Estimated (date passed)
This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated: December 14, 2023
Status Verified: December 2023
Last Update Submitted: December 11, 2023

Conditions

Aortic Infections and Inflammations

Outcome Measures

Primary Outcomes (1)

Aortic vascular graft or endograft infection
Determined by the MAGIC-criteria
At least 1 year follow-up

Eligibility Criteria

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

All patients with previous aortic vascular graft or endograft surgery in Skåne, Halland, Kronoberg and Blekinge between the years 2010-2021.

You may qualify if:

Previous aortic vascular graft or endograft infection with bloodstream infection.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Lund University
Otherlead

Study Sites (1)

Helsingborgs lasarett

Helsingborg, Sweden

RECRUITING

Adam CewersCONTACT

MeSH Terms

Conditions

Inflammation

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

Oskar Ljungquist
Lund University
PRINCIPAL INVESTIGATOR

Central Study Contacts

Oskar Ljungquist, M.D, PhD

CONTACT

+46424061000 oskar.ljungquist@med.lu.se

Torgny Sunnerhagen, M.D, PhD

CONTACT

torgny.sunnerhagen@med.lu.se

Study Design

Study Type: observational
Observational Model: COHORT
Time Perspective: RETROSPECTIVE
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

August 26, 2022

First Posted

August 30, 2022

Study Start

September 1, 2022

Actual (reported)

Primary Completion

September 1, 2024

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Study Completion

September 1, 2024

Estimated (date passed)

This estimate has passed. The registry has not confirmed an actual date for this milestone.

Last Updated

December 14, 2023

Record last verified: 2023-12

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT05521035
Data provider: ClinicalTrials.gov
Source updated: 2023-12-14
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:21:50 UTC

Locations

SE(1)

Risk and Incidence of Aortic Graft and Endograft Infection With BSI

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Links

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Source record

Locations